| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Francesco Ciccia | Q54153157 |
| Giuliana Guggino | Q56810321 | ||
| Paola Cipriani | Q42416415 | ||
| Roberto Giacomelli | Q42416418 | ||
| P2093 | author name string | A Ferrante | |
| G Triolo | |||
| P2860 | cites work | Immunopathology of synovitis: from histology to molecular pathways | Q26781647 |
| Regulation of human helper T cell subset differentiation by cytokines | Q26830939 | ||
| A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis | Q27680522 | ||
| The development and in vivo function of T helper 9 cells | Q28083375 | ||
| Functional expression of IL-9 receptor by human neutrophils from asthmatic donors: role in IL-8 release | Q28142994 | ||
| Signals from the IL-9 receptor are critical for the early stages of human intrathymic T cell development | Q28144007 | ||
| Medium- and large-vessel vasculitis | Q28196695 | ||
| Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis | Q28267120 | ||
| Heteromerization of the c Chain with the Interleukin-9 Receptor Subunit Leads to STAT Activation and Prevention of Apoptosis | Q29035592 | ||
| Differentiation of effector CD4 T cell populations (*) | Q29614838 | ||
| Th17 and Th1 T-cell responses in giant cell arteritis | Q33723160 | ||
| Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity | Q33915697 | ||
| A brief history of IL-9 | Q34168144 | ||
| Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis | Q34555643 | ||
| Immune mechanisms in medium and large-vessel vasculitis | Q34777943 | ||
| Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease | Q34791372 | ||
| Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis | Q34917019 | ||
| Increased Serum Interleukin-9 Levels in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Pathogenic Role or Just an Epiphenomenon? | Q35674703 | ||
| Subclinical gut inflammation in ankylosing spondylitis | Q35850022 | ||
| A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis. | Q44506483 | ||
| Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4(+) T helper type 1 subset differentiation | Q44761134 | ||
| Increased interleukin‑9 and CD4+IL-9+ T cells in patients with systemic lupus erythematosus | Q44823402 | ||
| IL-9-induced expansion of B-1b cells restores numbers but not function of B-1 lymphocytes in xid mice | Q44885066 | ||
| IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. | Q46209312 | ||
| IL-9, a local growth factor for synovial T cells in inflammatory arthritis | Q46979732 | ||
| Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model. | Q49148358 | ||
| Maturation-related histone modifications in the PU.1 promoter regulate Th9-cell development | Q50960795 | ||
| Expression of IL-9 receptor alpha chain on human germinal center B cells modulates IgE secretion. | Q51970900 | ||
| Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. | Q53446140 | ||
| TH9 cells that express the transcription factor PU.1 drive T cell–mediated colitis via IL-9 receptor signaling in intestinal epithelial cells | Q56671802 | ||
| Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis | Q61733518 | ||
| Interleukin-7 (IL-7) enhances class switching to IgE and IgG4 in the presence of T cells via IL-9 and sCD23 | Q74138210 | ||
| Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis | Q84637134 | ||
| Proteinase 3, the autoantigen in granulomatosis with polyangiitis, associates with calreticulin on apoptotic neutrophils, impairs macrophage phagocytosis, and promotes inflammation | Q84660942 | ||
| Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis | Q85001806 | ||
| Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis | Q85603999 | ||
| Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis | Q87093433 | ||
| Serum cytokine profile of unaffected first-degree relatives of patients with rheumatoid arthritis | Q87105289 | ||
| Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice | Q35946790 | ||
| Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis | Q36266550 | ||
| A deleterious role for Th9/IL-9 in hepatic fibrogenesis | Q36428081 | ||
| Detection and identification of protein citrullination in complex biological systems | Q36515404 | ||
| Paneth cells: leukocyte-like mediators of innate immunity in the intestine | Q36515928 | ||
| Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. | Q36639988 | ||
| Programmed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivity | Q36837356 | ||
| Potential roles of IL-9 in the pathogenesis of systemic lupus erythematosus | Q37021660 | ||
| Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA) | Q37053019 | ||
| IL-33-activated dendritic cells induce an atypical TH2-type response | Q37265087 | ||
| T cells in rheumatoid arthritis | Q37324840 | ||
| IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway | Q37362940 | ||
| IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation | Q37397810 | ||
| Th9 cells: differentiation and disease. | Q37696777 | ||
| Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patients | Q38162306 | ||
| T cell subsets and their role in the pathogenesis of rheumatic disease | Q38180303 | ||
| Key advances in the clinical approach to ANCA-associated vasculitis | Q38224803 | ||
| Advances in the management of psoriatic arthritis | Q38227264 | ||
| Transforming growth factor β--at the centre of systemic sclerosis | Q38241227 | ||
| IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease | Q38268321 | ||
| Citrullination and autoimmunity | Q38338006 | ||
| Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis | Q38366114 | ||
| Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis | Q38458004 | ||
| Etiology and Pathogenesis of Psoriatic Arthritis | Q38609827 | ||
| Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis | Q40608820 | ||
| MAP kinase activation by interleukin-9 in lymphoid and mast cell lines | Q40660999 | ||
| Interleukin-9: a T-cell growth factor with a potential oncogenic activity. | Q40860978 | ||
| The Th17/IL-23 Axis and Natural Immunity in Psoriatic Arthritis | Q42090633 | ||
| Functional and Phenotypic Plasticity of CD4(+) T Cell Subsets | Q43184369 | ||
| Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis | Q43205831 | ||
| IL-9 and its receptor are predominantly involved in the pathogenesis of UC. | Q43783161 | ||
| Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. | Q44453951 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 125-132 | |
| P577 | publication date | 2016-08-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Interleukin-9 and T helper type 9 cells in rheumatic diseases | |
| P478 | volume | 185 |
| Q93106999 | Bedside to bench: defining the immunopathogenesis of psoriatic arthritis |
| Q33830967 | Dynamics of Th9 cells and their potential role in immunopathogenesis of murine schistosomiasis |
| Q94484029 | IL-33/ST2/IL-9/IL-9R signaling disrupts ocular surface barrier in allergic inflammation |
| Q91645587 | IL-7 is a Key Driver Cytokine in Spondyloarthritis? |
| Q48168109 | Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients. |
| Q92634783 | T Helper 9 Cells: A New Player in Immune-Related Diseases |
| Q59040804 | The pathogenesis of psoriatic arthritis |
Search more.